Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SARILUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SARILUMAB: Safety Overview

Metric SARGRAMOSTIM SARILUMAB
Total FAERS Reports 593 21,493
Deaths Reported 85 1,983
Death Rate 14.3% 9.2%
Hospitalizations 138 3,538
Average Patient Age 34.4 yrs 57.5 yrs
% Female Patients 43.5% 84.4%
Manufacturer Partner Therapeutics, Inc. Sanofi-Aventis U.S. LLC
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription